Probiotic Formula
Natural health product licensed in Canada
- Licence holder
- Isagenix Canada ULC
- NPN or DIN-HM
- 80043647
- Status
- Inactive licence
- Licence date
- 16 July 2013
- Revision date
- 25 October 2013
- Form
- Comprimé, désagrégeant oralement
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium animalis subsp. lactis Source : BS-01 | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BS-01 | 10 mg | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 10 mg | Not calculated |
Non-medicinal ingredients
Crospovidone, Dioxyde de silicium, Xylitol, Croscarmellose de sodium, Stéarate de magnésium, D-Mannitol, Saveur de menthe
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 6 years | 1 Comprimé | 1 day |
Uses authorised in Canada
Provides live microorganisms that temporarily modify gut flora. Probiotics that temporarily modify gut flora. Source of probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhoea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
Source
Official Health Canada record, licence 80043647
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed. Photograph the packaging